@viennabiocenter.bsky.social
Research, Education and Business. Vienna BioCenter is a life science cluster that includes IMP, IMBA, GMI, Max Perutz Labs, as well as the Faculty of Life Science & CeMESS (both University of Vienna) and 35+ biotechs.
IMBA scientists have joined forces with three other organizations to accelerate research and potential treatments for Coffin-Siris syndrome, a rare ARID1B-linked disorder causing severe neurodevelopmental delays: https://imba.science/48wLU1o
05.12.2025 08:00 — 👍 2 🔁 1 💬 0 📌 0
In her wonderful podcast "Where the wild thoughts are", Jo Marchant has recently hosted Kristin Tessmar-Raible @univie.ac.at @awi.de @ercgrantees.bsky.social @viennabiocenter.bsky.social to discuss how the moon impacts biology. Full episode at shows.acast.com/where-the-wi...
25.11.2025 22:19 — 👍 5 🔁 2 💬 0 📌 0With the support of the @viennabiocenter.bsky.social Proteomics facility, the researchers developed an improved method for detecting SARs.
Read the paper now published in Developmental Cell: doi.org/10.1016/j.de...
Now hiring! The Mendjan Lab at IMBA in Vienna is looking for postdoctoral researchers to work on an ERC-funded project aiming to study human heart development and disease through pioneering cardiac organoid technology. More: https://imba.science/3Me3dgo
#research #jobs #europe #biology
New in @nature.com: The "Microflora Danica" project analyzed 10k+ samples to map Denmark's microbial life. Led by @aau.dk, Michael Wagner @michiwagner4.bsky.social, Daan Speth @daanspeth.bsky.social, Andrew Giguere @cemess.bsky.social @univie.ac.at analyzed nitrifiers.
03.12.2025 16:10 — 👍 12 🔁 4 💬 2 📌 2
The @viennabiocenter.bsky.social hosted a visit from the Business Agency of Vienna as part of @interreg.eu Austria-Czechia project, JOBITY. The learned about the Vienna BioCenter and the GMI, & toured the Core Facilities, heartbeat bio, Quantro Therapeutics & a:head with @lisavienna.bsky.social.
03.12.2025 13:47 — 👍 3 🔁 2 💬 1 📌 0
The Vienna BioCenter Out of the Box Award celebrates collaboration & creative thinking. This year 2 teams received the annual stipend, as both stood out for their creativity, collaboration & potential.
Learn more: lnkd.in/dz3iBU2E
@maxperutzlabs.ac.at @imbavienna.bsky.social @impvienna.bsky.social
Freshly out at @natcomms.nature.com ! Our @univie.ac.at @awi.de @viennabiocenter.bsky.social @ercgrantees.bsky.social research into neurogenic plasticity of adult worm brains, and similarities in stem cells supporting growth of camera-type eyes. www.nature.com/articles/s41... [1/7]
01.12.2025 10:51 — 👍 37 🔁 14 💬 1 📌 3
Magnus Nordborg from the Gregor Mendel Institute and Sasha Martens at the Max Perutz Labs Vienna were recently awarded Synergy Grants by the European Research Council (ERC)
@gmivienna.bsky.social @maxperutzlabs.ac.at
Read more about their projects: lnkd.in/d3w8y7ty
Georg Winter and first author Natalie Scholes (c) Barbara Bachmann/CeMM
New Study published in Nature by the group of @georgwinter.bsky.social, From Inhibition to Destruction - Kinase Drugs Found to Trigger Protein Degradation aithyra.at/news/ #AITHYRA #CeMM #TPD
26.11.2025 16:14 — 👍 17 🔁 6 💬 0 📌 0
Nature featured work from our Pauli lab, where AlphaFold-Multimer helped reveal how Tmem81 and two sperm proteins create the pocket for the egg protein Bouncer to bind.
Andrea Pauli: “AlphaFold speeds up discovery, we use it for every project.”
🔗 www.nature.com/articles/d41...
We are looking forward to welcoming #IanKuijt to #HEASVienna next week as part of the #HEASSeminar series in #ArchaeologicalScience.
More information and registration on our website. 👇🔗
The Vienna BioCenter Summer School 2026 call is now open for talented undergrads, it's a great opportunity for students who are interested in graduate study in the life sciences. Please RT
https://training.vbc.ac.at/summer-school/
Congratulations to Magnus Nordborg of the GMI and @oeaw.bsky.social who, together with Leandro Quadrana and @pierrebaduel.bsky.social, has received an @fwf-at.bsky.social Grant for the project “Genetic and epigenetic determinants of transposon dynamics”.
More here: www.oeaw.ac.at/gmi/detail/n...
Dr. Johannes Zuber is a Senior Group Leader at the Research Institute of Molecular Pathology (IMP) and an Adjunct Professor at the Medical University in Vienna. His lab develops and applies inducible loss-of-function genetic tools (iCas9, Tet-shRNAmir, ARTi, AID2), time-resolved transcriptomics, FACS-based and in-vivo screens to characterize regulatory pathways and dependencies in cancer and tumor-associated immune cells. He has been awarded with the German Cancer Prize in 2016 and elected as an EMBO member in 2022.
Are you interested in single-cell genomics and CRISPR applications? We’re thrilled to announce that the "High-Content CRISPR Screening" conference will take place on March 18-19, 2026, in Vienna, Austria.
Website: www.perturb2026.bio
Meet the Speaker: @johanneszuber.bsky.social
Screenshot new CeMESS website
Screenshot new EDGE website
Screenshot new TER website
It’s finally here! After months in the making, we’re thrilled to reveal the newly relaunched CeMESS website: cemess.univie.ac.at
Take a look at the new design – we’d love to hear what you think!
🚨 New paper alert!
Scientists in the Burga lab show for the first time how toxin-antidote elements—selfish genetic elements that perpetuate by poisoning those embryos that don’t inherit them—evolved from normal cellular proteins. More: https://imba.science/3M3fRyq
“A model for other EU countries.” - EU Commissioner for Start-ups, Research, and Innovation Ekaterina Zaharieva was impressed by the collaborations at the Vienna BioCenter during her visit to @aithyra.bsky.social
Read more (GER) : lnkd.in/dPGzWSTn
@oeaw.bsky.social
We’re excited to announce the expansion of Myllia’s global commercial leadership team: Neil Matharoo has joined as VP, Commercial, North America, and Henrik Schmidt has been promoted to VP, Commercial, Europe & APAC. Their expertise strengthens our ability to support partners worldwide as we advance next-generation CRISPR screening technologies! At Myllia Biotechnology, we’ve built a unique, scalable CRISPR screening platform: - Unbiased drug target discovery powered by high-throughput, pooled CRISPR screening - Primary human cell models that translate in vivo, e.g., T helper cells and myeloid cells - Single-cell resolution for deeply resolved functional genomics Get in touch via info@myllia.com and come join the “High-Content CRISPR Screening” conference in March 2026: www.perturb2026.bio #TeamMyllia #CRISPR #FunctionalGenomics #DrugDiscovery
We’re excited to announce the expansion of Myllia’s commercial team: Neil Matharoo has joined as VP, Commercial, North America, and Henrik Schmidt has been promoted to VP, Commercial, Europe & APAC. At @mylliabio.bsky.social, we’ve built a unique, scalable CRISPR screening platform!
25.11.2025 09:20 — 👍 4 🔁 2 💬 0 📌 0
“…[at the IMP] collaborations can develop naturally across many projects…”
We sat down with Jacob Schreiber after he wrapped up his one-year stay at the IMP, and he told us all about it: www.imp.ac.at/news/article...
@jmschreiber91.bsky.social, @viennabiocenter.bsky.social
Photo: CeMESS/Thomas Suchanek
Photo: CeMESS/Thomas Suchanek
Photo: CeMESS/Thomas Suchanek
Michael Zumstein leads the new CD Laboratory Photo: CeMESS/Thomas Suchanek
New CD Lab at CeMESS! Yesterday, @univie.ac.at inaugurated the Christian Doppler Laboratory for Biological Degradation of Water-Soluble Polymers, led by Michael Zumstein. Together with @bokuvienna.bsky.social & @basf.bsky.social, the lab tackles sustainable polymer management for a greener future.🔬💧
25.11.2025 14:40 — 👍 14 🔁 4 💬 1 📌 0
This year’s @embo.org Workshop is held at the @viennabiocenter.bsky.social. Open to 120 participants, it is over-enrolled with 180 attendees! Thank you to the organizers @isabelmonte.bsky.social, Aino Komatsu, @moodytomato.bsky.social, and Liam Dolan for making this event possible. #EMBOplantEvo
25.11.2025 15:29 — 👍 70 🔁 20 💬 0 📌 8The recording from this talk is now available on our YouTube channel 🔗👇
26.11.2025 10:34 — 👍 4 🔁 1 💬 0 📌 0
IMBA is recognized among Austria’s top public, non-university research institutions for its strong contribution to innovation and patent development, according to a new European study: www.oeaw.ac.at/imba/researc...
26.11.2025 15:05 — 👍 7 🔁 1 💬 0 📌 0
🎉 Congratulations to Nina Corsini and Oliver Eichmüller, researchers in Jürgen Knoblich’s lab at IMBA, who were recognized with the German Tuberous Sclerosis Foundation’s Award for their research on tuberous sclerosis using cerebral organoids. More: https://imba.science/3Jej5hy
16.10.2025 13:00 — 👍 10 🔁 2 💬 0 📌 0
RNA biology is a major research focus at the Perutz - and the new @fwf-at.bsky.social grants strengthen it even further 🙌 Elif Karagöz and Pavel Kovarik will investigate how RNA-binding proteins regulate cellular stress and immune responses ➡️ tinyurl.com/2s3f3mu8
@univie.ac.at
@meduniwien.ac.at
What’s it like doing a PhD between two labs? In our latest Behind the Science, Júlia Portell i de Montserrat, shared PhD student in the Plaschka lab at the IMP and the Brennecke lab at @imbavienna.bsky.social, tells us more about her unusual but rewarding PhD journey: bit.ly/3IHXtdp
13.10.2025 15:07 — 👍 7 🔁 2 💬 0 📌 0
Excited to present at the @metastasisresearch.bsky.social webinar soon. Registration is free!
13.10.2025 19:14 — 👍 19 🔁 5 💬 0 📌 0
PFAS in fish? @greenpeace.de found high #PFAS levels in marine animals from German North and Baltic Sea harbours – some exceeding EU limits.
In #ORF konkret, Thilo Hofmann (EDGE/CeMESS) explains what these “forever chemicals” mean for our environment and health.
🔗 on.orf.at/video/142952...
Dr. Xin Jin is an HHMI Freeman Hrabowski Scholar, Associate Professor of Neuroscience at Scripps Research, a member of the Dorris Neuroscience Center, and Adjunct Professor of Cognitive Science at UC San Diego. She received her BSc in Chemistry from MIT and her PhD in Biology from The Rockefeller University working in the Lab of Cori Bargmann. As a Junior Fellow at the Harvard Society of Fellows, she worked with Paola Arlotta, Feng Zhang and Aviv Regev to develop and apply in vivo genetic screening technologies to study brain development and homeostasis. She is the recipient of the Pew Biomedical Scholar, McKnight Scholar Award, Early Career Investigator Award from the International Society of Autism Research and was named as one of the ‘35 Innovators Under 35’ by MIT Tech Review.
The "High-Content CRISPR Screening" conference will take place on March 18-19, 2026, in Vienna, Austria. Don’t forget to register and submit an abstract!
Conference website: perturb2026.bio
Abstract submission: perturb2026.bio/abstract-sub...
Meet the Speaker: @xinjin.bsky.social
